Transcriptomics Market to be dominated by Consumables Product type through 2028
Increasing demand for precision medicine is expected to
drive the growth of global transcriptomics in the forecast period, 2024-2028.
According to TechSci Research report, “Transcriptomics Market -
Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F”, the
global transcriptomics market is anticipated to grow at an impressive rate in
the forecast period, 2024-2028. This can be ascribed to the increasing demand
for personalized medicine for the treatment of specific diseases in people,
worldwide. Additionally, rising development in research and development and its
expenditure, along with increasing investment by government organizations, especially
in the developed countries in the North America and Europe, are expected to
create lucrative opportunities for the market growth in coming years. Besides, increasing
attention on biomarker discovery and the growing application of toxic genomics are
further expected to support the market growth. Similarly, the growing application
of RNA sequencing along with the development of new transcriptomics products
further enhanced the demand for the development of novel drugs which will boost
the market growth during the forecast period. Also, increasing the number of
large key players across the globe will propel the growth of the
transcriptomics market during the forecast period.
However, the lack
of efficient data analysis tools is slowing down the growth of global transcriptomics
market in the forecast period. Similarly, increasing technological advances
create data complexity after analysis of transcripts through sequencing
platforms which will show negative results and may hamper the transcriptomics market
growth during the forecast period. Also, the lack of skilled professionals for
handling the transcriptomics in emerging countries can further restrict the
growth of global transcriptomics market. Similarly, high capital investment
requirements and data management issues may hamper the growth of the market
during the forecast period.
Browse over XX market data Figures spread through 110 Pages and an in-depth TOC on "Global Transcriptomics Market"
The global transcriptomics market can be segmented by component, by technology, by application, by end user and by region.
Based on component, the global transcriptomics
market can be segmented into Instruments,
Consumables, and Software & Services. The consumables segment dominated the market
in 2022 and is expected to continue maintaining its dominance throughout the
forecast period. This can be ascribed to increasing research and development
activities in the pharmaceutical industry along with rising demand for drug
development to cure diseases. Similarly, a growing number of clinical laboratories
is expected to enhance the demand for transcriptomics during the forecast
period.
Based on technology, the market can be
segmented Next Generation Sequencing, Polymerase Chain Reaction, Microarray,
In-Situ Hybridization, and Others.
The PCR segment is expected to dominate during the forecast period on account
of increasing number of COVID-19 cases, the rising use of genetic testing along
with increasing demand for transcriptomics for drug delivery. Similarly, the
growing discovery of new therapeutics compared to the traditional methods of
RNA-sequencing for the treatment of chronic diseases will boost the market
growth during the forecast period.
Major companies operating in the global transcriptomics market are:
- Agilent Technologies, Inc.
- ANGLE plc.
- Bio-Rad Laboratories, Inc.
- Becton, Dickinson, and Company
- Fluidigm Corporation
- BioSypder, Inc.
- Danaher Corporation (Cytiva)
- 10x Genomics, Inc.
- Pacific Biosciences of California, Inc.
- NanoString Technologies, Inc.
In February 2022, Moderna and Thermo Fisher
Scientific Announced a Long-Term Strategic Collaboration.
In April 2022, Scitara announced a
collaboration with PerkinElmer Informatics to create a new model of the modern
lab.
In May 2022, ResolveOME's Early Access
Program (EAP) was introduced by BioSkryb Genomics. The entire genome and
full-length mRNA transcripts of the entire transcriptome are amplified from the
same cell using this integrated, single-cell approach.
Download Free Sample Report
Customers can also request for 10% free customization on this report.
“North
America is expected to dominate in the global transcriptomics market,
due to the increasing demand for different types of chronic diseases such as
obesity, hepatitis B, and cancer among the population across the region. Similarly,
the growth in demand for faster testing for genetic testing and research will
enhance the demand for transcriptomics which will boost the market during the
forecast period. Furthermore, increasing number of key players in the market
along with growing development in the healthcare sector, complemented by increasing
investment by major key players to produce novel drugs, are further
contributing to the demand for transcriptomics. Besides, increasing favorable
government reimbursement policies, growing demand for new transcriptomics, and
growing awareness about the usage and benefits of transcriptomics in the region,
are further expected to create lucrative opportunities for the market growth”
said Mr. Karan Chechi, Research Director with TechSci Research, a research
based global management consulting firm.
“Transcriptomics Market - Global Industry Size, Share, Trends,
Opportunity, and Forecast, 2018-2028, Segmented
By Component (Instruments, Consumables, Software & Services), By Technology
(Next Generation Sequencing, Polymerase Chain Reaction, Microarray, In-Situ
Hybridization, Others), By Application (Drug Discovery & Development, Cell
Biology, Single Cell Analysis, Gene Expression, Others), By End User
(Biotechnology & Pharmaceutical Companies, Academic & Research
Institutions, Others), By
Region and Competition”, has
evaluated the future growth potential of global transcriptomics market
and provides statistics & information on market size, structure, and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in global transcriptomics market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com